| Institution: | 1. Wellcome Trust Centre for Molecular Parasitology, Institute of Infection, Immunity and Inflammation, University of Glasgow, Glasgow, G12 8TA, UK;2. Division of Biological Chemistry and Drug Discovery, University of Dundee, Dundee, DD1 5EH, UK;1. Nanyang Technological University, School of Biological Sciences, 60 Nanyang Drive, Singapore 637551, Singapore;2. Department of Immunology and Infectious Diseases, Harvard School of Public Health, Boston, MA 02115, USA;3. Singapore-MIT Alliance for Research and Technology (SMART)–Interdisciplinary Research Group in Infectious Diseases, Singapore 117456, Singapore;4. Department of Microbiology, Yong Loo Lin School of Medicine, National University of Singapore, National University Health System, Singapore 117545, Singapore;1. Center for Infectious Disease Research, Seattle, WA 98109, USA;2. Department of Global Health, University of Washington, Seattle, WA 98195, USA;1. Department of Immunology, University of Washington School of Medicine, 750 Republican Street, Seattle, WA 98109, USA;2. Center for Infectious Disease Research, 307 Westlake Avenue North, No. 500, Seattle, WA 98109, USA;1. Centre national de recherche et de formation sur le paludisme, Ouagadougou, Burkina Faso;2. Groupe de Recherche Action en Santé, Ouagadougou, Burkina Faso;3. Universite Bordeaux, Inserm, Bordeaux Population Health Research Center, CHU Bordeaux, EUCLID/F-CRIN Clinical Trials Platform, Bordeaux, France;4. CHU Bordeaux, Pôle de Santé Publique, Bordeaux, France;5. Inria SISTM team, Talence, France;6. Université de Paris, Biologie Intégrée du Globule Rouge, UMR_S1134, BIGR, INSERM, Paris, France;7. Institut National de la Transfusion Sanguine, Paris, France;8. Laboratory of excellence GR-Ex, Paris, France;9. INSERM U970, Paris Cardiovascular Research Centre, Université de Paris, Faculté de médecine, Hôpital Européen Georges Pompidou, Service d''Immunologie Biologique, Paris, France;10. Assistance Publique Hôpitaux de Paris, Hôpital Cochin, Plateforme d''immuno-monitoring vaccinal, Laboratoire d''Immunologie, Paris, France;11. Université de Paris, Faculté de médecine, INSERM, CIC 1417, Assistance Publique Hôpitaux de Paris, Hôpital Cochin, CIC Cochin Pasteur, Paris, France;12. European Vaccine Initiative, UniversitätsKlinikum Heidelberg, Heidelberg, Germany;13. INSERM, Institut de Santé Publique, Pôle de Recherche Clinique, Paris, France;14. Direction de la Recherche Clinique et de l''Innovation, Unité de sécurité et vigilance des Essais Cliniques, CHU de Bordeaux, Bordeaux, France |
